Andrew Lee is one of the co-founders and Chief Scientific Officer at IMCS. Andrew's educational background is in biochemistry. His passion for chromatography began during an internship at a research laboratory. Chromatography is a type of separation technology---the process involves separating a mixture from a medium in order to isolate a specific component (ex. protein).
Integrated Micro-Chromatography Systems (IMCS) creates, manufactures and distributes next-generation biotechnology products to clinical and forensic toxicology, academic research facilities, US Federal Government agencies and health science companies.